Accuray Incorporated announced that the Providence Swedish Radiosurgery Center in Seattle, Washington is enhancing its cancer treatment capabilities with the purchase of the latest generation CyberKnife®? S7?? System, the hospital's second CyberKnife radiation delivery device purchase.

The precision and accuracy enabled by the system's robotic design will also make it an ideal choice for the treatment of neurologic disorders. The new system will enable the medical team to deliver gold standard stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments faster than with previous models, expanding access to an effective and convenient option to more patients. The CyberKnife S7 System is a non-invasive radiation therapy device that was built from the ground-up to provide clinicians with the speed they need for operational efficiency without sacrificing the precision and accuracy required for stereotactic radiosur surgery (SRS) and stereOTactic body radiation therapy (S BRT).

The system uses artificial intelligence (AI) to track and automatically adapt for tumor or patient movement during treatment, delivering the radiation dose directly to the target with sub-millimeter precision - in as little as 15 minutes. The Providence Swedish Radiosurgery center team has made significant contributions to the field of radiation medicine including leading the first large, multi-center clinical trial with long-term follow-up evaluating the use of SBRT in prostate cancer delivered by the CyberKnife System. They also are actively involved in research assessing the use of SBRT to treat tumors in other areas of the body and radiosurgery in the treatment of cancer and medical conditions in the brain.